Navigation Links
Cardiome Announces Upcoming Presentation Of Results Of Phase 2b Clinical Trial Of Vernakalant (Oral) At The European Society Of Cardiology Congress 2009
Date:8/28/2009

ts containing the words "believe", "may", "plan", "will", "estimate", "continue", "anticipate", "intend", "expect" and similar expressions. Such forward-looking statements or information involve known and unknown risks, uncertainties and other factors that may cause our actual results, events or developments, or industry results, to be materially different from any future results, events or developments expressed or implied by such forward-looking statements or information. Such factors include, among others, our stage of development, lack of product revenues, additional capital requirements, risk associated with the completion of clinical trials and obtaining regulatory approval to market our products, the ability to protect our intellectual property, dependence on collaborative partners and the prospects for negotiating additional corporate collaborations or licensing arrangements and their timing. Specifically, certain risks and uncertainties that could cause such actual events or results expressed or implied by such forward-looking statements and information to differ materially from any future events or results expressed or implied by such statements and information include, but are not limited to, the risks and uncertainties that: we, together with our collaborative partners, may not be able to successfully develop and obtain regulatory approval for vernakalant (iv) or vernakalant (oral) in the treatment of atrial fibrillation or any other current or future products in our targeted indications; our future operating results are uncertain and likely to fluctuate; we may not be able to raise additional capital; we may not be successful in establishing additional corporate collaborations or licensing arrangements; we may not be able to establish marketing and sales capabilities and the costs of launching our products may be greater than anticipated; we rely on third parties for the continued supply and manufacture of vernakalant (iv) and vernakalant (oral) and we
'/>"/>
SOURCE Cardiome Pharma Corp.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Cardiome Pharma Corp. Announces Tender Offer To Purchase Up To US$27.5 Million Of Its Common Shares
2. Atherotech Adds New Cardiometabolic Tests Amid Strong 2009 Growth
3. Cardiome to Hold Conference Call
4. Cardiome Announces Management Transition
5. Cardiome Achieves Milestone From Collaboration With Merck Co., Inc.
6. Cardiome Announces That Collaboration and License Agreement with Merck & Co., Inc. Now Effective
7. Cardiome Reports First Quarter Results
8. Cardiome to Hold Conference Call
9. CardioCareLive.com, First Ever Online Cardiometabolic Conference, Revolutionizes Continuing Medical Education for Cardiovascular Healthcare Professionals
10. Cardiome Reports 2008 Results
11. CardioCareLive, First-Ever Online Cardiometabolic Conference, Debuts Today
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... ... September 03, 2015 , ... The Linda Hall Library ... of a comet, the IceCube observatory at the South Pole, and the interior of ... Fall Lecture Series for the world's foremost independently funded research library devoted to science, ...
(Date:9/3/2015)... ... September 03, 2015 , ... ... provider of comprehensive eating disorder treatment for adults and adolescents struggling with ... Calinoiu, MD has joined the medical treatment team. As a Staff Psychiatrist, ...
(Date:9/3/2015)... York, New York (PRWEB) , ... September 03, 2015 , ... ... of the Division of Trauma, Burns, Critical and Acute Care at NewYork-Presbyterian/Weill Cornell Medical ... College. , Dr. Winchell is a nationally renowned expert in care for the critically ...
(Date:9/3/2015)... ... , ... Global Vision , the world leader in the development of ... and artwork inspection solutions, ScanProof and ArtProof at Packaging Innovations 2015. ... booth #F33 , Be the first to get a sneak peek of Intelligent Proofreading. ...
(Date:9/3/2015)... ... 03, 2015 , ... Atlantic Information Services, Inc. (AIS) is ... Strategies for a Rapidly Changing Marketplace.” In this Sept. 16 program, pharmacy benefit ... how plan sponsors are adopting bold, innovative strategies to control soaring specialty pharmacy ...
Breaking Medicine News(10 mins):Health News:Facing the Frontiers of Science and Technology The Linda Hall Library Announces 2015 Fall Lecture Series Featuring Experiences from the South Pole to Outer Space 2Health News:Facing the Frontiers of Science and Technology The Linda Hall Library Announces 2015 Fall Lecture Series Featuring Experiences from the South Pole to Outer Space 3Health News:Facing the Frontiers of Science and Technology The Linda Hall Library Announces 2015 Fall Lecture Series Featuring Experiences from the South Pole to Outer Space 4Health News:Facing the Frontiers of Science and Technology The Linda Hall Library Announces 2015 Fall Lecture Series Featuring Experiences from the South Pole to Outer Space 5Health News:Ileana Calinoiu, MD Joins Eating Recovery Center of Washington Medical Treatment Team 2Health News:Ileana Calinoiu, MD Joins Eating Recovery Center of Washington Medical Treatment Team 3Health News:Trauma Expert Joins NewYork-Presbyterian Hospital and Weill Cornell Medical College 2Health News:Trauma Expert Joins NewYork-Presbyterian Hospital and Weill Cornell Medical College 3Health News:Trauma Expert Joins NewYork-Presbyterian Hospital and Weill Cornell Medical College 4Health News:Trauma Expert Joins NewYork-Presbyterian Hospital and Weill Cornell Medical College 5Health News:Global Vision to Spotlight Intelligent Proofreading at Packaging Innovations 2015 2Health News:Global Vision to Spotlight Intelligent Proofreading at Packaging Innovations 2015 3Health News:Speakers for Upcoming AIS Virtual Conference on Pharmacy Benefit Strategies Include Executives from CVS Health, Express Scripts 2
... BROOK, Ill. January 25, 2008 A recent ... that hospitalizations for disorders caused by gastroesophageal reflux disease or ... for patients who had milder forms of GERD (in addition ... 216 percent during the same time period. The numbers underscore ...
... AARP CEO Bill Novelli,made the following statement about next Monday,s ... & Perata) by the California State Senate,Committee on Health:, ... we strongly,urge the members of the State Senate Health Committee ... vote next Monday. ABX 1 1 represents a major step ...
... Role of Certifying Boards in Quality Measurement ... that PQRI,- Medicare,s new program for rewarding ... improved, the Senate Finance Committee has issued,recommendations ... Services (CMS) to,include alternatives for measuring and ...
... a speech,earlier this week, Wal-Mart Chief Executive Officer ... stages of offering pharmacy benefit manager,services. In response ... the National Community Pharmacists Association (NCPA) issued the,following ... be reformed. The current PBM business,model is one ...
... Tech associate professor of biological sciences, has an original theory ... $150,000 grant from Space Florida to test it. The grant ... Health Branch. , He is also the sole medical researcher ... Kennedy Space Center (KSC) and the research is being conducted ...
... of a drug to activate stem cells that differentiate into ... may be a potential treatment strategy for osteoporosis, according to ... The study led by researchers from Massachusetts General ... found that treatment with a medication used to treat bone ...
Cached Medicine News:Health News:ASGE encourages patients to see a physician if they experience symptoms suggestive of GERD 2Health News:ASGE encourages patients to see a physician if they experience symptoms suggestive of GERD 3Health News:ASGE encourages patients to see a physician if they experience symptoms suggestive of GERD 4Health News:Senate Finance Committee Recommends Ways That Medicare Can Enhance Current Physician Quality Reporting Initiative (PQRI) 2Health News:NCPA Statement on Wal-Mart's Entry Into the Pharmacy Benefit Market 2Health News:Controversial theory of Alzheimer's origin funded 2Health News:Turning on adult stem cells may help repair bone 2
(Date:9/3/2015)... PLEASANTON, Calif. , Sept. 3, 2015 /PRNewswire/ ... detailed in a white paper released by ... the Agency for Healthcare Research & Quality (AHRQ), ... an estimated $9.1-$11.6 billion annually . In addition ... result in litigation, government penalties, and negatively impact ...
(Date:9/3/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/4q3mv2/investigation ) has announced ... Olmesartan Market, 2010-2019" report to their offering. ... by Sankyo Pharmaceuticals Co., Ltd and was patented in ... by FDA to enter the American market in May. ... the world after it succeeded in the US market. ...
(Date:9/3/2015)... 03, 2015 Research and ... the "Investigation Report on China,s Bromhexine Market, 2010-2019" ... pollution worsens, the incidence of respiratory disease keeps growing ... Bromhexine, a semisynthetic derivative of vasicine, is a mucolytic ... asthma associated with viscid or excessive mucus. It can ...
Breaking Medicine Technology:Four Financial Reasons to Reduce Pressure Ulcer Incidents: Leaf Healthcare Releases White Paper on Direct and Indirect Costs Associated with Pressure Ulcers 2Four Financial Reasons to Reduce Pressure Ulcer Incidents: Leaf Healthcare Releases White Paper on Direct and Indirect Costs Associated with Pressure Ulcers 3China Olmesartan Investigation Market Report 2010-2019 2China Bromhexine Market Report 2015-2019 2
... Trial Raise Questions for,Patients, OAK BROOK, Ill., ... Trial, published in the September 18 issue of ... the technology,s,ability to diagnose intermediate- to large-sized polyps ... not as effective in diagnosing small polyps. CT,colonography ...
... Study Results Published in the September 18th New England ... die from colorectal cancer. Many,of these deaths could be ... 50 and older who should be screened for the ... cost, inconvenience, and safety,concerns associated with current screening exams., ...
Cached Medicine Technology:ASGE Encourages Patients to Speak to Their Doctor About Colorectal Cancer Screening Options 2ASGE Encourages Patients to Speak to Their Doctor About Colorectal Cancer Screening Options 3ASGE Encourages Patients to Speak to Their Doctor About Colorectal Cancer Screening Options 4ASGE Encourages Patients to Speak to Their Doctor About Colorectal Cancer Screening Options 5MultiVu Video Feed: Major Trial Demonstrates Comparable Accuracy of Virtual Colonoscopy and Standard Colonoscopy 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: